Last reviewed · How we verify
NCT04091633: SHINE
School Health Implementation Network: Eastern Mediterranean
NA trial testing WHO School Mental Health Program in Behavioral Symptoms in 971 participants. Completed in 22 April 2022.
30 June 2021
Quick facts
| Lead sponsor | Human Development Research Foundation, Pakistan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 971 |
| Start date | 7 October 2019 |
| Primary completion | 30 June 2021 |
| Estimated completion | 22 April 2022 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- WHO School Mental Health Program
- Enhanced School Mental Health Program (eSMHP)
Conditions studied
- Behavioral Symptoms — all drugs for Behavioral Symptoms →
- Behavioral Problem — all drugs for Behavioral Problem →
- Emotional Problem — all drugs for Emotional Problem →
- Emotional Stress — all drugs for Emotional Stress →
Sponsor
Human Development Research Foundation, Pakistan
Who can join
Adults 8 to 13, any sex, with Behavioral Symptoms or Behavioral Problem. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background An estimated 10-20% of children globally are affected by a mental health problem. Child mental health has been identified as a priority issue by the World Health Organization's Eastern Mediterranean Regional Office (WHO EMRO). Following consultations with international and regional experts and stakeholders, WHO EMRO developed an evidence-based School Mental Health Program (SMHP), endorsed by WHO EMRO member countries, including Pakistan. The federal and provincial health departments in Pakistan made recommendations for a phased implementation of the SMHP in a pilot district. In the formative phase of this program, a number of implementation challenges were identified by the stakeholders. Broadly, these included the need to operationalize and adapt the existing components of the intervention to the local context and to develop sustainable mechanisms for delivery of quality training and supervision. Informed by the results of a formative phase investigations, the SHINE scale-up research team adapted the SMHP (henceforth called Conventional SMHP or cSMHP) to address these implementation challenges. The enhanced version of the intervention is called Enhanced School Mental Health Program (eSMHP). Enhancements to cSMHP have occurred at two levels: A) Content enhancements, such as a collaborative care model for engaging parents/primary caregivers, strategies for teacher's wellbeing, and adaptation and operationalization of particular clinical intervention strategies and B) Technological enhancements which include adaptation of the training manual for delivery using an online training platform, and a 'Chat-bot' to aid the implementation of intervention strategies in classroom settings. Objectives The primary objective of the study is to evaluate the effectiveness of eSMHP in reducing socio-emotional difficulties in school-going children, aged 8-13, compared to cSMHP in Gujar Khan, a rural sub-district of Rawalpindi, Pakistan. The secondary objectives are to compare the cost-effectiveness, acceptability, adoption, appropriateness (including cultural appropriateness), feasibility, penetration and sustainability of scaled-up implementation of eSMHP and cSMHP. It is hypothesized that eSMHP will prove to be both more effective and more scalable than cSMHP. Study population The research is embedded within the phased district level implementation of the cSMHP in Rawalpindi, Pakistan. The study population will consist of children of both genders, aged 8-13 (n=960) with socio-emotional difficulties, studying in rural public schools of sub-district Gujar Khan in Rawalpindi. Design The proposed study design is a cluster randomized controlled trial (cRCT), embedded within the conventional implementation of the SMHP. Following relevant ethics committees and regulatory approvals, 80 eligible schools, stratified by gender, will be randomized into intervention and control arms with a 1:1 allocation ratio. Following informed consent from the parent/ primary caregiver, children will be screened for socio-emotional difficulties using Strengths and Difficulties Questionnaire (SDQ). 960 children scoring \> 12 on the teacher-rated SDQ total difficulty scores and \> 14 on the parent-rated SDQ total difficulty scores will be recruited and equally randomized into intervention and control arms (480 in each arm). Teachers in the intervention arm will receive training in eSMHP, whereas teachers in the active control will be trained in cSMHP. Trained teachers will deliver the program to children in their respective arms. Outcome measures Primary Outcome: The primary outcome is reduction in socio-emotional total difficulties scores, measured with the parent-rated SDQ, 9 months after commencing intervention delivery. Secondary Outcomes: Implementation data on acceptability, adoption, appropriateness (including cultural appropriateness), feasibility, penetration and sustainability outcomes will be collected from children, parents/primary caregivers, head teachers and teachers. In addition, data will be collected on self-reported Psychological Outcome Profiles (PSYCHLOPS)-KIDS to measure progress on psycho-social problems and wellbeing; annual academic performance; classroom absenteeism, stigmatizing experiences and parent-teacher interaction. Data on teachers' sense of efficacy and subjective well-being, and on the schools' psychosocial environment profile will be collected. All secondary outcome data will be collected at baseline and 9 months after commencing intervention delivery. Outcomes will be analyzed on an intention to treat basis. The role of various factors as potential mediators and moderators eSMHP effectiveness will be explored. Cost-effectiveness evaluation of SMHP shall be evaluated in terms of costs associated with implementation of eSMHP compared with cSMHP.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Technology-Assisted Teachers' Training to Promote Socioemotional Well-Being of Children in Public Schools in Rural Pakistan.
Hamdani SU, Zill-e-Huma, Warraitch A, Suleman N, et al · · 2021 · cited 6× · PMID 32838678 · DOI 10.1176/appi.ps.202000005
Verify or expand the search:
- PubMed search for NCT04091633
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Behavioral Symptoms
Currently open trials in the same condition.
- NCT06511908 — Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resi · Phase 2 · recruiting
- NCT06462196 — Natural History of Depression, Bipolar Disorder and Suicide Risk · recruiting
- NCT06105736 — Regulating Together in Tuberous Sclerosis Complex · NA · recruiting
- NCT05322343 — Biobank and Brain Health in Bordeaux. · recruiting
- NCT06225661 — Focused Suicide Prevention Strategy for Youth Presenting to the Emergency Department With Suicide Related Behaviour · NA · active not recruiting
Other Human Development Research Foundation, Pakistan trials
Trials by the same sponsor.
- NCT05353491 — Thinking Healthy Program-Technology Assisted (THP-TA) · NA · completed
- NCT04255472 — Effectiveness of the WHO Caregivers Skills Training Program · NA · unknown
- NCT04252807 — A Common Elements-based Intervention to Improve Maternal Psychological Well-being and Mother-infant Interaction · NA · completed
- NCT04254393 — Early Adolescent Skills for Emotions (EASE)-Pilot Cluster Randomized Controlled Trial (cRCT) in Public Schools of Rural · NA · completed
- NCT03762421 — Improving Psychological Well-being of Trainee Civil Servants in Pakistan · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04091633 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Human Development Research Foundation, Pakistan
- Last refreshed: 3 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04091633.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing